Markets › India › NSE › CONCORDBIO

Concord Biotech Ltd

NSE:CONCORDBIOHealthcareNSE:CNX500NSE:NIFTY500_EW

₹1,285.80−3.97%At closeAt close · Mon 19 Oct · ≈ AED 49.68 · Market cap $1.47B · Next earnings Wed 18 Nov

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-07-31	7.33	5.59	−23.7%	2,724.6	2,575.0	−5.5%
2026-05-29	8.90	8.50	−4.5%	3,761.8	3,261.0	−13.3%
2026-02-11	7.20	6.30	−12.5%	2,813.0	2,778.0	−1.2%
2025-11-13	5.30	6.10	+15.1%	2,523.5	2,471.0	−2.1%
2025-09-30	5.30	6.03	+13.8%	2,523.5	2,470.6	−2.1%
2025-08-08	6.15	4.20	−31.7%	2,369.5	2,040.0	−13.9%
2025-06-30	6.15	4.21	−31.5%	2,369.5	2,039.9	−13.9%
2025-05-29	10.04	13.39	+33.4%	3,639.0	4,296.0	+18.1%
2025-02-13	8.90	7.30	−18.0%	2,835.7	2,442.0	−13.9%
2024-11-11	—	9.20	—	2,843.0	3,102.0	+9.1%
2024-08-10	6.50	5.70	−12.3%	2,283.0	2,158.0	−5.5%
2024-08-09	6.50	5.70	−12.3%	2,283.0	2,158.0	−5.5%